Results 231 to 240 of about 10,488 (304)
Tumor marker pseudoprogression and immune-related cholangitis during conversion therapy for massive hepatocellular carcinoma: a case report. [PDF]
Zhang X +8 more
europepmc +1 more source
Control survey of radioimmunoassay-.ALPHA.-fetoprotein and a study on reference standard.
Kyoko Shibata +3 more
openalex +2 more sources
ABSTRACT Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome is a rare inflammatory arthritis of older adults. We report a 92‐year‐old man who presented with fatigue and distal pitting edema, fulfilling the clinical features of RS3PE.
Ken Sato
wiley +1 more source
Normalization of serum alpha fetoprotein after direct acting antivirals in hepatitis C patients lowers hepatocellular carcinoma risk. [PDF]
Lin CK, Wang SH, Lee TH.
europepmc +1 more source
ABSTRACT Aims Early detection is essential for improving hepatocellular carcinoma's (HCC) prognosis. However, the diagnostic performance of the current interventions remains unsatisfactory, particularly in patients with cirrhotic nodules. We aimed to develop a predictive model for the early detection of HCC using circulating tumor DNA (ctDNA) profiles ...
Li‐Jun Chang +6 more
wiley +1 more source
The Expression of Alpha-Fetoprotein in Human Blastocoel Fluid-Conditioned Media In Vitro: A Proof of Concept Study. [PDF]
Kavoussi SK +8 more
europepmc +1 more source
ABSTRACT Aim The gut microbiome modulates immune responses, and butyrate‐producing bacteria have been linked to improved immune checkpoint inhibitor (ICI) efficacy. Conversely, proton pump inhibitors (PPIs) may negatively impact ICI outcomes by altering gut microbiota.
Kazuhiro Nouso +34 more
wiley +1 more source
Construction of a nomogram for predicting the risk of primary liver cancer occurrence in patients with liver cysts using CT imaging features combined with alpha-fetoprotein. [PDF]
Jin ZL, Zhao LJ.
europepmc +1 more source
ABSTRACT Hereditary tyrosinemia type I (HT‐1) is a rare metabolic disorder treated by NTBC, requiring careful therapeutic and nutritional monitoring. While follow‐up traditionally relies on urinary succinylacetone, plasma NTBC and plasma amino acids, dried blood spot (DBS) methods have introduced alternative monitoring options.
Anne‐Sophie Adam +7 more
wiley +1 more source

